All Stories

  1. Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria
  2. Novel Tricarbonylrhenium-Anthrapyrazole Complexes with DNA-Binding and Antitumor Properties: In Vitro and In Vivo Pharmacokinetic Studies with 99mTc-Analogue
  3. One-Pot, Multi-Component Green Microwave-Assisted Synthesis of Bridgehead Bicyclo[4.4.0]boron Heterocycles and DNA Affinity Studies
  4. Erbium(III) complexes with fluoroquinolones: Structure and biological properties
  5. Coordination Compounds of Nickel(II) with 3,5–Dibromo–Salicylaldehyde: Structure and Interaction with Biomolecules
  6. Copper(II) complexes with non-steroidal anti-inflammatory drugs and neocuproine: Structure and biological evaluation
  7. Cu(ii) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach
  8. Coordination compounds of cobalt(ii) with carboxylate non-steroidal anti-inflammatory drugs: structure and biological profile
  9. Neutral and cationic nickel(II) complexes with substituted salicylaldehydes: Characterization, antibacterial activity, and interaction with biomacromolecules
  10. Transition metal(II) complexes with the non–steroidal anti–inflammatory drug oxaprozin: Characterization and biological profile
  11. Erbium(III) coordination compounds with substituted salicylaldehydes: Characterization and biological profile
  12. pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies
  13. Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules
  14. Metal Complexes with Naphthalene-Based Acetic Acids as Ligands: Structure and Biological Activity
  15. Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells
  16. Copper(II) complexes with 3,5–dihalogeno–salicylaldehydes: Synthesis, structure and interaction with DNA and albumins
  17. Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH3-Substituted Thiadiazole-Based Thioamide
  18. Copper(II) Complexes of 5–Fluoro–Salicylaldehyde: Synthesis, Characterization, Antioxidant Properties, Interaction with DNA and Serum Albumins
  19. Copper(II) complexes with 4-(diethylamino)salicylaldehyde and α-diimines: Anticancer, antioxidant, antigenotoxic effects and interaction with DNA and albumins
  20. Palladium(II) Complexes of Substituted Salicylaldehydes: Synthesis, Characterization and Investigation of Their Biological Profile
  21. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
  22. Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile
  23. Structure and in vitro and in silico biological activity of zinc(II) complexes with 3,5–dichloro–salicylaldehyde
  24. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity
  25. Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study
  26. Manganese(II) complexes of substituted salicylaldehydes and α-diimines: Synthesis, characterization and biological activity
  27. Zinc(II) complexes of 3,5–dibromo–salicylaldehyde and α–diimines: Synthesis, characterization and in vitro and in silico biological profile
  28. Stimuli-responsive spin crossover nanoparticles for drug delivery and DNA-binding studies
  29. Zinc(ii) complexes of 3-bromo-5-chloro-salicylaldehyde: characterization and biological activity
  30. Transition metal(ii) complexes of halogenated derivatives of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: structure, antioxidant activity, DNA-binding DNA photocleavage, interaction with albumin andin silicostudies
  31. Silver(i) complexes bearing heterocyclic thioamide ligands with NH2 and CF3 substituents: effect of ligand group substitution on antibacterial and anticancer properties
  32. Copper(II) complexes with non–steroidal anti–inflammatory drugs: Structural characterization, in vitro and in silico biological profile
  33. Synthesis, characterization and (in vitro and in silico) biological activity of a series of dioxouranium(VI) complexes with non-steroidal anti-inflammatory drugs
  34. Nickel(II)–meclofenamate complexes: Structure, in vitro and in silico DNA– and albumin–binding studies, antioxidant and anticholinergic activity
  35. Structure and biological profile of transition metal complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline
  36. Trinuclear and tetranuclear iron(III) complexes with fenamates: Structure and biological profile
  37. Copper(II) complexes with meclofenamate ligands: Structure, interaction with DNA and albumins, antioxidant and anticholinergic activity
  38. Interaction of manganese(II) with the hybrid molecule (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: Structure and biological profile
  39. Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin
  40. Facile Method to Prepare pH-Sensitive PEI-Functionalized Carbon Nanotubes as Rationally Designed Vehicles for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery
  41. Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin
  42. Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA
  43. Structure and biological evaluation of pyridine-2-carboxamidine copper(II) complex resulting from N′-(4-nitrophenylsulfonyloxy)2-pyridine-carboxamidoxime
  44. Copper(II) and zinc(II) coordination compounds of non-steroidal anti-inflammatory drugs: Structural features and antioxidant activity
  45. Transition metal complexes with a novel guanine-based (E)-2-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazolin-4(3H)-one: Synthesis, characterization, interaction with DNA and albumins and antioxidant activity
  46. p-Pyridinyl oxime carbamates: synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies
  47. Manganese(II) coordination compounds of carboxylate non-steroidal anti-inflammatory drugs
  48. Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
  49. A palladium(II) complex with the Schiff base 4-chloro-2-(N-ethyliminomethyl)-phenol: Synthesis, structural characterization, and in vitro and in silico biological activity studies
  50. Bi- and trinuclear copper(I) compounds of 2,2,5,5-tetramethyl-imidazolidine-4-thione and 1,2-bis(diphenylphosphano)ethane: Synthesis, crystal structures, in vitro and in silico study of antibacterial activity and interaction with DNA and albumins
  51. Cobalt(II) complexes with the non-steroidal anti-inflammatory drug diclofenac and nitrogen-donor ligands
  52. Synthesis, characterization and biological activity of Zn coordination compounds with the quinolone gatifloxacin
  53. Zinc-oxaprozin compounds: Synthesis, structure and biological activity
  54. Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies
  55. Organometallic rhenium tricarbonyl–enrofloxacin and –levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies
  56. Palladium(II) complexes with salicylaldehyde ligands: Synthesis, characterization, structure, in vitro and in silico study of the interaction with calf-thymus DNA and albumins
  57. Manganese coordination compounds of mefenamic acid: In vitro screening and in silico prediction of biological activity
  58. Manganese(II) complexes of tolfenamic acid or naproxen in polymeric structures or encapsulated in [15-MC-5] manganese(III) metallacrowns: Structure and biological activity
  59. Copper(II) diclofenac complexes: Synthesis, structural studies and interaction with albumins and calf-thymus DNA
  60. Heterocyclic thioamide/phosphine mixed-ligand silver(I) complexes: Synthesis, molecular structures, DNA-binding properties and antibacterial activity
  61. Manganese(II) complexes of the quinolone family member flumequine: Structure, antimicrobial activity and affinity for albumins and calf-thymus DNA
  62. A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity
  63. Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity
  64. Extending the family of quinolone antibacterials to new copper derivatives: self-assembly, structural and topological features, catalytic and biological activity
  65. Manganese(ii) complexes with the non-steroidal anti-inflammatory drugs naproxen and mefenamic acid: synthesis, structure, antioxidant capacity, and interaction with albumins and DNA
  66. Nickel(II)-indomethacin mixed-ligand complexes: Synthesis, characterization, antioxidant activity and interaction with DNA and albumins
  67. Interaction of zinc(II) with the non-steroidal anti-inflammatory drug niflumic acid
  68. Toward Multifunctional Materials Incorporating Stepladder Manganese(III) Inverse-[9-MC-3]-Metallacrowns and Anti-Inflammatory Drugs
  69. Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity, and in vitro and in silico study of the interaction with DNA and albumins
  70. Synthesis, structural, thermal characterization and interaction with calf-thymus DNA and albumins of cationic Ni(II) complexes with 2,2′-dipyridylamine and salicylaldehydes
  71. Nickel(ii)–naproxen mixed-ligand complexes: synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  72. Copper(I) halide complexes of 2,2,5,5-tetramethyl-imidazolidine-4-thione: Synthesis, structures, luminescence, thermal stability and interaction with DNA
  73. Copper(II) complexes with gatifloxacin
  74. Zinc complexes of flufenamic acid: Characterization and biological evaluation
  75. Ni(II) complexes with 2,2-dipyridylamine and salicylaldehydes: Synthesis, crystal structure and interaction with calf-thymus DNA and albumins
  76. Nickel(II) complexes of flufenamic acid: Characterization, structure and interaction with DNA and albumins
  77. Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  78. Cobalt(II) complexes of sparfloxacin
  79. Nickel-diflunisal complexes: synthesis, characterization, in vitro antioxidant activity and interaction with DNA and albumins
  80. Characterization and biological properties of copper(II)-ketoprofen complexes
  81. Dinuclear copper(I) complexes of N-methylbenzothiazole-2-thione: synthesis, structures, antibacterial activity and DNA interaction
  82. Co-NSAIDs
  83. Synthesis, characterization and biological evaluation of 99m Tc/Re–tricarbonyl quinolone complexes
  84. Pyridine and p-Nitrophenyl Oxime Esters with Possible Photochemotherapeutic Activity: Synthesis, DNA Photocleavage and DNA Binding Studies
  85. Alkyl and aryl sulfonyl p-pyridine ethanone oximes are efficient DNA photo-cleavage agents
  86. Cd - 5-Cl-saloH
  87. Cd - 5-Br-saloH
  88. Evaluation of O-alkyl and aryl sulfonyl aromatic and heteroaromatic amidoximes as novel potent DNA photo-cleavers
  89. Structure and biological activities of metal complexes of flumequine
  90. New copper(ii) complexes of the anti-inflammatory drug mefenamic acid: a concerted study including synthesis, physicochemical characterization and their biological evaluation
  91. On the Complexity of Dynamic Mechanism Design
  92. Copper(II) Inverse-[9-Metallacrown-3] Compounds Accommodating ­Nitrato or Diclofenac Ligands: Structure, Magnetism, and Biological Activity
  93. Cd - 5-nitro-saloH
  94. Mn-diclofenac complexes
  95. Copper-tolfenamato complexes
  96. Mn3-diclofenac
  97. Ni - mefanamato complexes
  98. Manganese(II)–sparfloxacinato complexes
  99. Cobalt-oxolinato complexes
  100. Cu - saloH
  101. Copper(II)–indomethacin complexes
  102. Thermal analysis and structural characterization of copper(II) complexes with salicyladehydes
  103. Cobalt(II) complexes of enrofloxacin
  104. Synthesis, thermal analysis, and spectroscopic and structural characterizations of tetranuclear nickel(II) cubane-type clusters with 2-hydroxybenzaldehydes or 2-hydroxyphenones
  105. Synthesis, characterization, thermal and DNA-binding properties of new zinc complexes with 2-hydroxyphenones
  106. Zinc-tolfenamato
  107. Manganese(II) complexes of tolfenamic acid
  108. Zinc complexes of mefenamic acid
  109. Zn saloH
  110. Nickel complexes of diclofenac
  111. New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
  112. Copper(II) complexes of flufenamic acid
  113. Manganese(II) complexes of niflumic acid
  114. Zinc complexes of oxolinic acid, flumequine, enrofloxacin
  115. Manganese(II) complexes of oxolinic acid and enrofloxacin
  116. Metal complexes of quinolones or NSAIDs: Perspective
  117. Zinc complexes of flumequine
  118. Copper complexes with ofloxacin and norfloxacin - synthesis, structure na bioactivity
  119. Copper(II) complexes of flumequine
  120. A [24-MC-6] Zinc Metallacoronate with a Nonsteroidal Antiinflammatory Drug as the Constructing Ligand
  121. First Palladium(II) and Platinum(II) Complexes from Employment of 2,6-Diacetylpyridine Dioxime: Synthesis, Structural and Spectroscopic Characterization, and Biological Evaluation
  122. Cobalt(II)-tolfenamato complexes
  123. Cobalt - naproxen
  124. Zinc complexes of tolfenamic acid
  125. Copper - diflunisal
  126. Nickel–quinolones-bipyam complexes
  127. Copper(II) complexes of naproxen / diclofenac
  128. Copper(ii) complexes of mefenamic acid
  129. Zinc complexes of sparfoxacin - levofloxacin
  130. Nickel complexes of enrofloxacin
  131. Nickel complexes of flumequine
  132. Metal - sparfloxacin complexes
  133. Zinc(II) complexes of enrofloxacin
  134. Nickel complexes of oxolinic acid
  135. Cobalt(ii) complexes of mefenamic acid
  136. Nickel complexes of sparfloxacin
  137. Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
  138. Structure, cyclic voltammetry and DNA-binding properties of the bis(pyridine)bis(sparfloxacinato)nickel(II) complex
  139. Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]
  140. Zinc-oxolinato complexes
  141. Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties
  142. Magnesium complexes of ciprofloxacin
  143. Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)–sparfloxacin complex
  144. Mononuclear metal complexes of the second-generation quinolone antibacterial agent enrofloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  145. Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure–activity relationship
  146. Novel Copper(II) Complex ofN-Propyl-norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities
  147. Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin
  148. Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  149. Mononuclear copper(II) complexes with quinolones and nitrogen-donor heterocyclic ligands: Synthesis, characterization, biological activity and interaction with DNA
  150. Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation
  151. Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid
  152. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: Synthesis, structure and bioactivity
  153. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex
  154. Metal-pipemidato complexes
  155. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine
  156. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid
  157. Copper-enrofloxacin complexes
  158. Cu(II) - sparfloxacin
  159. Metal-piroxicam complexes
  160. An Unprecedented Trinuclear Structure Involving Two High-Spin and One Spin-Crossover Iron(II) Centers
  161. Host-Guest Interaction of 12-MC-4, 15-MC-5, and Fused 12-MC-4 Metallacrowns with Mononuclear and Binuclear Carboxylato Complexes: Structure and Magnetic Behavior
  162. Preparation of Site-Differentiated Mixed Ligand and Mixed Ligand/Mixed Metal Metallacrowns
  163. Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity
  164. Structurally Diverse Copper(II)−Carboxylato Complexes:  Neutral and Ionic Mononuclear Structures and a Novel Binuclear Structure
  165. Ni metallacrowns hosting a carboxylic herbicide
  166. CuII-herbicide complexes: structure and bioactivity
  167. Structurally diverse copper(II) herbicide complexes: mono- and bi-nuclear neutral or cationic complexes
  168. Mn(II) - MCPA